Undisclosed Polymer-Drug Conjugate(s)
Oncology (specifics undisclosed)
Pre-clinicalActive
Key Facts
Indication
Oncology (specifics undisclosed)
Phase
Pre-clinical
Status
Active
Company
About Nemucore Medical Innovations
Nemucore Medical Innovations is a preclinical-stage biotech company pioneering polymer-based nanomedicine platforms for targeted cancer therapy. The company's technology aims to encapsulate and deliver chemotherapeutic agents more precisely to tumor sites, potentially improving efficacy and safety profiles. Operating as a private entity since 2008, it appears to be in a pre-revenue, research and development-focused phase. Its success hinges on advancing its platform through preclinical validation and securing partnerships or funding to initiate clinical trials.
View full company profileTherapeutic Areas
Other Oncology (specifics undisclosed) Drugs
| Drug | Company | Phase |
|---|---|---|
| Innovation Portfolio (505(b)(2)) | 6S Pharma | Pre-clinical |
| Triomab® Platform Candidates | Lindis Biotech | Clinical Stage (Phase unspecified) |